Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.63
+0.63 (0.98%)
At close: Mar 20, 2026, 4:00 PM EDT
65.92
+1.29 (2.00%)
After-hours: Mar 20, 2026, 7:44 PM EDT

Utah Medical Products Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
38.5240.950.2252.2849.05
Revenue Growth (YoY)
-5.83%-18.56%-3.94%6.58%16.30%
Cost of Revenue
-16.7620.1920.0918.14
Gross Profit
2224.1430.0432.230.92
Selling, General & Admin
9.939.7412.711.9111.51
Research & Development
0.670.810.560.490.53
Total Operating Expenses
10.610.5513.2612.4112.04
Operating Income
11.413.5916.7819.7918.88
Interest Income
-3.383.060.680.18
Other Non-Operating Income (Expense)
--0.170.260.19-
Total Non-Operating Income (Expense)
-3.213.310.870.18
Pretax Income
14.1116.820.0920.6619.06
Provision for Income Taxes
-2.933.454.194.27
Net Income
14.1113.8716.6416.4714.79
Net Income to Common
14.1113.8716.6416.4714.79
Net Income Growth
1.70%-16.60%0.98%11.39%36.95%
Shares Outstanding (Basic)
34444
Shares Outstanding (Diluted)
34444
Shares Change (YoY)
-7.51%-3.68%-0.17%-0.46%-0.33%
EPS (Basic)
3.483.964.584.534.05
EPS (Diluted)
3.483.964.574.524.04
EPS Growth
-12.04%-13.35%1.11%11.88%37.41%
Free Cash Flow
014.621.6420.3420.65
Free Cash Flow Growth
--32.53%6.41%-1.52%7.13%
Free Cash Flow Per Share
-4.175.955.585.64
Dividends Per Share
1.2251.2051.1851.1650.855
Dividend Growth
1.66%1.69%1.72%36.26%-23.66%
Gross Margin
57.12%59.03%59.81%61.58%63.03%
Operating Margin
29.60%33.23%33.40%37.85%38.49%
Profit Margin
36.63%33.92%33.12%31.51%30.15%
FCF Margin
0.00%35.70%43.09%38.90%42.10%
EBITDA
11.416.4423.1526.8726.16
EBITDA Margin
29.60%40.19%46.08%51.40%53.34%
EBIT
11.413.5916.7819.7918.88
EBIT Margin
29.60%33.23%33.40%37.85%38.49%
Effective Tax Rate
0.00%17.43%17.19%20.26%22.42%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q